Combination Therapy with MAPK-Pathway-Specific Inhibitor and Folic-Acid-Receptor-Targeted Selenium Nanoparticles Induces Synergistic Antiproliferative Response in BRAF Mutant Cancer Cells
- 22 March 2019
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Biomaterials Science & Engineering
- Vol. 5 (5) , 2222-2234
Abstract
Combination chemotherapy, where drugs with non-overlapping mode of actions achieve better efficacy at lower doses with reduced dose-dependent side effects, holds promise for complete remission of tumor. Herein, we report a combination therapeutic module comprised of folic acid receptor (FAR)-targeted SeNPs (FA-SeNPs) and MAPK pathway inhibitor PD98059 (PD98). While aberrant signaling leading to uncontrolled proliferation in BRAF-mutation bearing cancer cells including MDAMB231 (breast cancer) and A375 (melanoma) cells was inhibited by PD98, high expression of FAR by these cells also led to selective internalization of FA-SeNPs. Consequently, the combination treatment of PD98 and FA-SeNPs demonstrated synergistic anti-proliferative efficacy in MDAMB231 and A375 cells involving apoptotic mode of cell death. The selective nature of the present combination module was supported by low off-target response in L132 non-cancerous lung cells. Moreover, the size of three-dimensional MDAMB231 spheroids was successfully reduced because of the combination therapy projecting its potential in eradicating tumor in vivo.Keywords
Funding Information
- Department of Science and Technology, Ministry of Science and Technology (SB/FTP/ETA-0122/2014)
- Department of Biotechnology , Ministry of Science and Technology (BT/PR13560/COE/34/44/2015, DBT-NER/Health/47/2015)
- Department of Electronics and Information Technology, Ministry of Communications and Information Technology (5(9)/2012-NANO (Vol. II))
This publication has 51 references indexed in Scilit:
- Effect of selenium nanoparticles with different sizes in primary cultured intestinal epithelial cells of crucian carp, Carassius auratus gibelioInternational Journal of Nanomedicine, 2013
- Structural basis for molecular recognition of folic acid by folate receptorsNature, 2013
- Folic Acid Functionalized Nanoparticles for Enhanced Oral Drug DeliveryMolecular Pharmaceutics, 2012
- Folate-targeted docetaxel-lipid-based-nanosuspensions for active-targeted cancer therapyInternational Journal of Nanomedicine, 2012
- Molecular mechanisms of acquired resistance to tyrosine kinase targeted therapyMolecular Cancer, 2010
- Folic Acid-Conjugated Chitosan Nanoparticles Enhanced Protoporphyrin IX Accumulation in Colorectal Cancer CellsBioconjugate Chemistry, 2010
- Methylselenol, a Selenium Metabolite, Induces Cell Cycle Arrest in G1 Phase and Apoptosis via the Extracellular-Regulated Kinase 1/2 Pathway and Other Cancer Signaling GenesThe Journal of Nutrition, 2009
- A Reliable Tool to Determine Cell Viability in Complex 3-D Culture: The Acid Phosphatase AssaySLAS Discovery, 2007
- The BRAF–MAPK signaling pathway is essential for cancer-immune evasion in human melanoma cellsJournal of Experimental Medicine, 2006
- Chromatin condensation during apoptosis is accompanied by degradation of lamin A+B, without enhanced activation of cdc2 kinase.Journal of Cell Biology, 1994